Michael Laule MD, Charité Hospital, Berlin, Germany presented data on Vivasure Medical’s Frontier III clinical study at PCR London Valves 2017. Frontier III was a multi-centre study evaluating Vivasure’s absorbable patch-based large arteriotomy closure device, in patients undergoing TAVR, EVAR and TEVAR.
Vivasure's PerQseal® Vascular Technology exhibited and presented at TCT 2017:
Michael Laule MD, Charité Hospital, Berlin, Germany presented an interactive poster on the Frontier III clinical results at the Large Bore Vascular Access and Closure session on Monday, October 30th.
Jeffrey J. Popma, MD, Beth Israel Deaconess Medical Center, Boston, MA presented the PerQseal® vascular technology during a session entitled Transcatheter Aortic Valve Therapies – Part 2, New Technologies Forum, on Tuesday, October 31st.
New York, USA